160 related articles for article (PubMed ID: 36230585)
1. Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins.
Caputo D; Coppola A; Quagliarini E; Di Santo R; Capriotti AL; Cammarata R; Laganà A; Papi M; Digiacomo L; Coppola R; Pozzi D; Caracciolo G
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230585
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Levitation of Personalized Nanoparticle-Protein Corona as an Effective Tool for Cancer Detection.
Quagliarini E; Digiacomo L; Caputo D; Coppola A; Amenitsch H; Caracciolo G; Pozzi D
Nanomaterials (Basel); 2022 Apr; 12(9):. PubMed ID: 35564106
[TBL] [Abstract][Full Text] [Related]
3. Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients.
Di Santo R; Digiacomo L; Quagliarini E; Capriotti AL; Laganà A; Zenezini Chiozzi R; Caputo D; Cascone C; Coppola R; Pozzi D; Caracciolo G
Front Bioeng Biotechnol; 2020; 8():491. PubMed ID: 32523944
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
Caputo D; Caracciolo G
Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection.
Caputo D; Quagliarini E; Pozzi D; Caracciolo G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142503
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection.
Caputo D; Quagliarini E; Coppola A; La Vaccara V; Marmiroli B; Sartori B; Caracciolo G; Pozzi D
Int J Surg; 2023 Oct; 109(10):2934-2940. PubMed ID: 37352522
[TBL] [Abstract][Full Text] [Related]
7. Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer.
Palchetti S; Caputo D; Digiacomo L; Capriotti AL; Coppola R; Pozzi D; Caracciolo G
Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30650541
[TBL] [Abstract][Full Text] [Related]
8. Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test.
Digiacomo L; Quagliarini E; Pozzi D; Coppola R; Caracciolo G; Caputo D
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296945
[TBL] [Abstract][Full Text] [Related]
9. Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles.
Digiacomo L; Caputo D; Coppola R; Cascone C; Giulimondi F; Palchetti S; Pozzi D; Caracciolo G
Biointerphases; 2021 Feb; 16(1):011010. PubMed ID: 33706529
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer.
Caputo D; Digiacomo L; Cascone C; Pozzi D; Palchetti S; Di Santo R; Quagliarini E; Coppola R; Mahmoudi M; Caracciolo G
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396882
[TBL] [Abstract][Full Text] [Related]
11. Improving the accuracy of pancreatic cancer clinical staging by exploitation of nanoparticle-blood interactions: A pilot study.
Caputo D; Cartillone M; Cascone C; Pozzi D; Digiacomo L; Palchetti S; Caracciolo G; Coppola R
Pancreatology; 2018 Sep; 18(6):661-665. PubMed ID: 29914752
[TBL] [Abstract][Full Text] [Related]
12. Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles.
Digiacomo L; Quagliarini E; La Vaccara V; Coppola A; Coppola R; Caputo D; Amenitsch H; Sartori B; Caracciolo G; Pozzi D
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680304
[TBL] [Abstract][Full Text] [Related]
13. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Levitation Patterns of Microfluidic-Generated Nanoparticle-Protein Complexes.
Digiacomo L; Quagliarini E; Marmiroli B; Sartori B; Perini G; Papi M; Capriotti AL; Montone CM; Cerrato A; Caracciolo G; Pozzi D
Nanomaterials (Basel); 2022 Jul; 12(14):. PubMed ID: 35889600
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology and pancreatic cancer management: State of the art and further perspectives.
Caputo D; Pozzi D; Farolfi T; Passa R; Coppola R; Caracciolo G
World J Gastrointest Oncol; 2021 Apr; 13(4):231-237. PubMed ID: 33889275
[TBL] [Abstract][Full Text] [Related]
16. Converting the personalized biomolecular corona of graphene oxide nanoflakes into a high-throughput diagnostic test for early cancer detection.
Papi M; Palmieri V; Digiacomo L; Giulimondi F; Palchetti S; Ciasca G; Perini G; Caputo D; Cartillone MC; Cascone C; Coppola R; Capriotti AL; Laganà A; Pozzi D; Caracciolo G
Nanoscale; 2019 Aug; 11(32):15339-15346. PubMed ID: 31386742
[TBL] [Abstract][Full Text] [Related]
17. Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma.
Vareed SK; Bhat VB; Thompson C; Vasu VT; Fermin D; Choi H; Creighton CJ; Gayatri S; Lan L; Putluri N; Thangjam GS; Kaur P; Shabahang M; Giri JG; Nesvizhskii AI; Asea AA; Cashikar AG; Rao A; McLoughlin J; Sreekumar A
PLoS One; 2011 Mar; 6(3):e17177. PubMed ID: 21448452
[TBL] [Abstract][Full Text] [Related]
18. The functional dissection of the plasma corona of SiO₂-NPs spots histidine rich glycoprotein as a major player able to hamper nanoparticle capture by macrophages.
Fedeli C; Segat D; Tavano R; Bubacco L; De Franceschi G; de Laureto PP; Lubian E; Selvestrel F; Mancin F; Papini E
Nanoscale; 2015 Nov; 7(42):17710-28. PubMed ID: 26451907
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
[TBL] [Abstract][Full Text] [Related]
20. A protein corona-enabled blood test for early cancer detection.
Caputo D; Papi M; Coppola R; Palchetti S; Digiacomo L; Caracciolo G; Pozzi D
Nanoscale; 2017 Jan; 9(1):349-354. PubMed ID: 27924334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
